Dr. Biernacka is a board-certified anatomic pathologist and cytopathologist with expertise in breast pathology. She works closely with other members of the Multidisciplinary Breast Program at the University of Chicago, providing comprehensive and coordinated care to breast cancer patients. Her clinical and research interests center on the morphologic and molecular features of breast diseases, with a special focus on apocrine lesions and androgen receptor signaling in breast cancer.
Massachusetts General Hospital
Fellowship - Breast Pathology
2017
Dartmouth-Hitchcock
Fellowship - Cytopathology
2016
Baylor College of Medicine
Residency - Anatomic Pathology
2015
Albert Einstein College of Medicine
Postdoctoral Fellowship
2012
The Medical University of Lodz
Poland
PhD
2012
Anderson Cancer Center
MD
2010
The Medical University of Lodz
Poland
MD
2006
Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung.
Cytomorphologic and molecular characterization of spindle cell carcinoid tumors of the lung. Cancer Cytopathol. 2024 Jul 18.
PMID: 39024046
Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization.
Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization. Cancer Med. 2024 Jan 02.
PMID: 38164123
Exposure of Keratinocytes to Candida Albicans in the Context of Atopic Milieu Induces Changes in the Surface Glycosylation Pattern of Small Extracellular Vesicles to Enhance Their Propensity to Interact With Inhibitory Siglec Receptors.
Exposure of Keratinocytes to Candida Albicans in the Context of Atopic Milieu Induces Changes in the Surface Glycosylation Pattern of Small Extracellular Vesicles to Enhance Their Propensity to Interact With Inhibitory Siglec Receptors. Front Immunol. 2022; 13:884530.
PMID: 35784319
Applications of nanodosimetry in particle therapy planning and beyond.
Applications of nanodosimetry in particle therapy planning and beyond. Phys Med Biol. 2021 12 10; 66(24).
PMID: 34731854
Brain Tissue Low-Level Mosaicism for MTOR Mutation Causes Smith-Kingsmore Phenotype with Recurrent Hypoglycemia-A Novel Phenotype and a Further Proof for Testing of an Affected Tissue.
Brain Tissue Low-Level Mosaicism for MTOR Mutation Causes Smith-Kingsmore Phenotype with Recurrent Hypoglycemia-A Novel Phenotype and a Further Proof for Testing of an Affected Tissue. Diagnostics (Basel). 2021 Jul 15; 11(7).
PMID: 34359351
Histopathologic and clinical outcomes of Milan System categories "non-diagnostic" and "non-neoplastic" of salivary gland fine needle aspirations.
Histopathologic and clinical outcomes of Milan System categories "non-diagnostic" and "non-neoplastic" of salivary gland fine needle aspirations. J Am Soc Cytopathol. 2021 Jul-Aug; 10(4):349-356.
PMID: 33867311
Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone.
Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone. Acta Cytol. 2021; 65(2):140-149.
PMID: 33535202
High-resolution, ultrasensitive and quantitative DNA double-strand break labeling in eukaryotic cells using i-BLESS.
High-resolution, ultrasensitive and quantitative DNA double-strand break labeling in eukaryotic cells using i-BLESS. Nat Protoc. 2021 02; 16(2):1034-1061.
PMID: 33349705
Correction to: Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
Correction to: Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):967.
PMID: 32170477
Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sites.
Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sites. Nat Commun. 2020 08 07; 11(1):3940.
PMID: 32769985